未登录

汤

汤继辉 (Jihui Tang)

the third affiliated hospital

H指数:12

被引数:441

个人简介

任职于安徽医科大学，担任安徽省药剂学委员会委员、《安徽医药》杂志编委，入选第三批安徽医科大学校级优秀青年教师，获2015年度安徽医科大学十佳科技新星称号。2012年毕业于中国药科大学，获药剂学博士学位。2013年9月至2016年2月在安徽医科大学从事博士后研究工作，2016年2月至3月在澳大利亚塔斯马尼亚大学学术交流，2016年9月至2017年9月在美国东北俄亥俄医科大学访学。

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chemically programmable hybrid membrane-camouflaged acetate gossypol prodrug reprograms the hepatic microenvironment for the treatment of liver fibrosis

化学可编程的杂化膜伪装醋酸棉酚前药重编程肝微环境以治疗肝纤维化

Journal of Nanobiotechnology

IF12.6

2026-07-310

OA

Study on the Physical Properties and Application of a Novel Pharmaceutical Excipient Made from Starch and Cellulose Co-Processing

关于由淀粉和纤维素共处理制备的一种新型药用辅料物理性质与应用的研究

Pharmaceuticals 2025, Vol. 18, Page 1389

IF4.8

2025-09-210

OAAI

Impact of droplet size and surface charge on oral bioavailability of Norcantharidin-loaded SEDDS: Mechanistic insights into lymphatic transport and intestinal permeability

纳卡纳特里定（Norcantharidin）负载自乳化药物递送系统（SEDDS）中液滴尺寸和表面电荷对口服生物利用度的影响：淋巴转运和肠道渗透机制的见解

Journal of Pharmaceutical Sciences

IF3.8

2025-07-080

PRE

Development and in vitro-in vivo evaluation of a novel sustained-release tablet based on constant-release surface

基于恒定释放表面的新型缓释片的开发及体外-体内评价

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

IF4.9

2025-03-011

PRE

Advances in Cyclodextrins and Their Derivatives in Nano-Delivery Systems

IF5.5

2024-08-093

OAAI

Highway Visibility Level Prediction Using Geometric and Visual Features Driven Dual-Branch Fusion Network

IEEE TRANSACTIONS ON INTELLIGENT TRANSPORTATION SYSTEMS

IF8.4

2024-08-010

PRE

Time-programmed activation of CD47 disruption and immunogenic cell death with Cas9 ribonucleoprotein nanocapsule for improved cancer immunotherapy

使用Cas9核糖核蛋白纳米胶囊对CD47破坏和免疫原性细胞死亡进行时间程序化激活，以改善癌症免疫疗法

CHEMICAL ENGINEERING JOURNAL

IF13.2

2023-10-014

PRE

Advances in Self-Assembled Peptides as Drug Carriers

自组装多肽作为药物载体的研究进展

IF5.5

2023-02-0117

OAAI

Novel active stealth micelles based on β2M achieved effective antitumor therapy

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-07-014

OAAI

Nanomicelle-Microsphere Composite as a Drug Carrier to Improve Lung-Targeting Specificity for Lung Cancer

IF5.5

2022-02-2510

OAAI

Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy

IF8.1

2021-12-2935

OA

Rapid Production of a Novel Al(III) Dependent Bioflocculant Isolated From Raoultella ornithinolytica 160-1 and Its Application Combined With Inorganic Salts

FRONTIERS IN MICROBIOLOGY

IF4.5

2021-01-1211

OAAI

Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake

ACTA PHARMACEUTICA SINICA B

IF14.6

2017-05-0179

OAAI

Preparation and In Vitro/In Vivo Evaluation of Puerarin Solid Self-Microemulsifying Drug Delivery System by Spherical Crystallization Technique

AAPS PHARMSCITECH

IF4

2015-12-2219

OAAI

The role of the cell cycle in the cellular uptake of folate-modified poly(L-amino acid) micelles in a cell population

IF5.1

2015-01-0117

PREAI

Synthesis and Characterization of 3D CuO Hierarchical Structure by Nanoplates Two-Step Self-Assembly

ASIAN JOURNAL OF CHEMISTRY

IF0

2014-01-012

OAAI

In vivo pharmacokinetics, biodistribution and antitumor effect of amphiphilic poly(L-amino acids) micelles loaded with a novel all-trans retinoic acid derivative

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2014-01-0110

PREAI

HPLC-DAD method for comprehensive quality control of Semen Strychni

PHARMACEUTICAL BIOLOGY

IF4.8

2013-07-0512

OAAI